Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Clofarabine × 1 year × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Myeloid, Acute 4 Lymphoma, Non-Hodgkin 3 Myelodysplastic Syndromes 2 Leukemia, Myelomonocytic, Chronic 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Anemia, Refractory, with Excess of Blasts 2 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Lymphoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1 Hemoglobinopathies 1 Hematologic Neoplasms 1 Graft vs Host Disease 1 Bone Marrow Failure Disorders 1 Advanced Urothelial Carcinoma 1

Interventions

Cyclophosphamide 11 blinatumomab 8 fludarabine 7 venetoclax 6 fludarabine phosphate 5 Cytarabine 5 Rituximab 4 Lenalidomide 4 Dexamethasone 4 Blood Specimen Collection 4 Azacitidine 4 obinutuzumab 3 daratumumab 3 pembrolizumab 2 nilotinib 2 Vincristine 2 Radiotherapy 2 Methotrexate 2 Melphalan 2 Immunotherapy, Adoptive 2 Imatinib Mesylate 2 Idarubicin 2 Daunorubicin 2 Dasatinib 2 Chemotherapy, Adjuvant 2 trastuzumab deruxtecan 1 tislelizumab 1 tisagenlecleucel 1 thymoglobulin 1 tetrathiomolybdate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡